(RTTNews) – Novocure (NVCR) reported a third quarter net loss of $37.3 million compared to a loss of $30.6 million, prior year. Net loss per ordinary share was $0.33 compared to a loss of $0.28. Analysts on average expected the company to report a loss per share of $0.42, for the quarter. Analysts’ estimates typically exclude special items.
Total net revenues for the quarter were $167.2 million, an increase of 8% compared to the same period in 2024. The company said this increase was primarily driven by active patient growth, as well as $3.3 million in exchange rate benefits.
Shares of Novocure are up 7% in pre-market trade on Thursday.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect…
